Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sovner

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
HMO Practice|August 7, 1990
An HMO psychopharmacology serviceR Sovner, K P Bailey, R E Weisblatt
Psychosomatics|March 1, 1978
Tardive dyskinesia and informed consentR Sovner, A Dimascio, D Berkowitz, et al.
The Journal of Clinical Psychiatry|October 1, 1989
Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled personsJ J Ratey, R Sovner, E Mikkelsen, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1991
A scale for evaluating emotional disorders in severely and profoundly mentally retarded persons. Development of the Diagnostic Assessment for the Severely Handicapped (DASH) scaleJ L Matson, W I Gardner, D A Coe, et al.
The Journal of Nervous and Mental Disease|September 1, 1991
A factor analytic study of the Diagnostic Assessment for the Severely Handicapped ScaleJ L Matson, D A Coe, W I Gardner, et al.
Journal of Intellectual Disability Research : JIDR|June 1, 1993
Fluoxetine treatment of depression and associated self-injury in two adults with mental retardationR Sovner, C J Fox, M J Lowry, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled studyJ Levine, N R Schooler, J Severe, et al.
Archives of General Psychiatry|November 1, 1984
Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measuresG Gardos, J O Cole, R M Rapkin, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
HMO Practice|August 7, 1990
An HMO psychopharmacology serviceR Sovner, K P Bailey, R E Weisblatt
Psychosomatics|March 1, 1978
Tardive dyskinesia and informed consentR Sovner, A Dimascio, D Berkowitz, et al.
The Journal of Clinical Psychiatry|October 1, 1989
Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled personsJ J Ratey, R Sovner, E Mikkelsen, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1991
A scale for evaluating emotional disorders in severely and profoundly mentally retarded persons. Development of the Diagnostic Assessment for the Severely Handicapped (DASH) scaleJ L Matson, W I Gardner, D A Coe, et al.
The Journal of Nervous and Mental Disease|September 1, 1991
A factor analytic study of the Diagnostic Assessment for the Severely Handicapped ScaleJ L Matson, D A Coe, W I Gardner, et al.
Journal of Intellectual Disability Research : JIDR|June 1, 1993
Fluoxetine treatment of depression and associated self-injury in two adults with mental retardationR Sovner, C J Fox, M J Lowry, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled studyJ Levine, N R Schooler, J Severe, et al.
Archives of General Psychiatry|November 1, 1984
Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measuresG Gardos, J O Cole, R M Rapkin, et al.
Pageof 4